pleading falsity when ads use peer-reviewed scientific study
43(B)log
JANUARY 21, 2022
Guardant Health, Inc. Natera, Inc., 18, 2022) Guardant sued its competitor Natera over an alleged “campaign of false and misleading advertising directed at” Guardant’s new product Reveal, a liquid biopsy cancer assay for early-stage colorectal cancer (CRC). 2022 WL 162706, No. 21-cv-04062-EMC (N.D.
Let's personalize your content